Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | CYP46A1 | Q9Y6A2 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8359584 | 1.00 | MEN1 (0.41) | MEN1KMT2ASMN1; SMN2HPGDMAPT | |
| SCHEMBL23712859 | 0.86 | CA12 (0.44) | MEN1KMT2AHPGDMAPTKDM4E | |
| SCHEMBL26714248 | 0.84 | NPC1 (0.45) | MEN1KMT2ASMN1; SMN2HPGDMAPT | |
| SCHEMBL23712595 | 0.84 | ALDH1A1 (0.39) | MEN1KMT2ASMN1; SMN2HPGDMAPT | |
| SCHEMBL23712868 | 0.84 | MEN1 (0.31) | MEN1KMT2AMAPTGAA | |
| SCHEMBL23733261 | 0.84 | MEN1 (0.31) | MEN1KMT2A | |
| SCHEMBL26717199 | 0.83 | NPC1 (0.35) | MEN1KMT2ASMN1; SMN2NPC1KDM4E | |
| SCHEMBL25469133 | 0.83 | HDAC8 (0.44) | SMN1; SMN2MAPTNPC1KDM4EALDH1A1 | |
| SCHEMBL23712694 | 0.82 | NPC1 (0.35) | MEN1KMT2ASMN1; SMN2NPC1KDM4E | |
| SCHEMBL26714243 | 0.82 | GAA (0.37) | MEN1KMT2ASMN1; SMN2HPGDMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230354808-A1 | METHOD OF CONTROLLING SOYBEAN RUST FUNGUS RESISTANT TO QOI FUNGICIDE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-11-09 | — | — | US | disclosed |
| US-20230150909-A1 | PHENYLACETIC ACID DERIVATIVE, USE THEREFOR, AND PRODUCTION INTERMEDIATE THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-05-18 | — | — | US | disclosed |
| EP-3778550-A1 | CYCLOPROPYL ETHYLENE COMPOUND AND ARTHROPOD PEST CONTROL COMPOSITION CONTAINING SAME | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2021-02-17 | — | — | EP | disclosed |
| WO-1999028305-A1 | FUNGICIDAL CYCLIC AMIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1999-06-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230354808-A1 | METHOD OF CONTROLLING SOYBEAN RUST FUNGUS RESISTANT TO QOI FUNGICIDE | SQOR, CYC1, COX5B | MEN1 1521/4885KMT2A 2867/4885SMN1; SMN2 3939/4885 |
| US-20230150909-A1 | PHENYLACETIC ACID DERIVATIVE, USE THEREFOR, AND PRODUCTION INTERMEDIATE THEREOF | FAR1, NOTUM, ME1 | MEN1 3096/4885KMT2A 567/4885SMN1; SMN2 4429/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.